StonvexLoading…
StonvexStonvexStonvexCore line items from TZOO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $91.72M | $83.90M | $84.48M | $70.60M |
Operating Income | $6.90M | $18.50M | $15.57M | $7.56M |
Net Income | $4.70M | $13.56M | $12.37M | $6.63M |
EPS (Diluted) | $0.41 | $1.06 | $0.83 | $0.53 |
Total Assets | $45.19M | $54.72M | $55.38M | $67.27M |
Total Liabilities | $47.61M | $50.37M | $46.50M | $58.42M |
Cash & Equivalents | $10.01M | $17.06M | $15.71M | $18.69M |
Free Cash Flow OCF − CapEx | $5.60M | $20.92M | $10.42M | $-23.58M |
Shares Outstanding | 10.93M | 11.84M | 13.57M | 15.70M |